TY - BOOK AU - Ellenberg, S. S. AU - Fleming, T. R. AU - DeMets, D. L. PY - 2003 DA - 2003// TI - Data monitoring committees in clinical trials: a practical perspective PB - Sons CY - Hoboken ID - Ellenberg2003 ER - TY - BOOK AU - Herson, J. PY - 2009 DA - 2009// TI - Data and safety monitoring committees in clinical trials PB - Francis CY - Boca Raton UR - https://doi.org/10.1201/9781420070392 DO - 10.1201/9781420070392 ID - Herson2009 ER - TY - JOUR AU - Anand, S. S. AU - Wittes, J. AU - Yusuf, S. PY - 2011 DA - 2011// TI - What information should a sponsor of a randomized trial receive during its conduct? JO - Clin Trials VL - 8 UR - https://doi.org/10.1177/1740774511424421 DO - 10.1177/1740774511424421 ID - Anand2011 ER - TY - BOOK AU - Friedman, L. M. AU - Furberg, C. AU - DeMets, D. L. PY - 1998 DA - 1998// TI - Fundamentals of clinical trials PB - Springer CY - New York UR - https://doi.org/10.1007/978-1-4757-2915-3 DO - 10.1007/978-1-4757-2915-3 ID - Friedman1998 ER - TY - JOUR AU - Grant, A. M. AU - Altman, D. G. AU - Babiker, A. B. AU - Campbell, M. K. AU - Clemens, F. J. AU - Darbyshire, J. H. AU - Elbourne, D. R. AU - McLeer, S. K. AU - Parmar, M. K. AU - Pocock, S. J. PY - 2005 DA - 2005// TI - Issues in data monitoring and interim analysis of trials JO - Health Technol Assess VL - 9 UR - https://doi.org/10.3310/hta9070 DO - 10.3310/hta9070 ID - Grant2005 ER - TY - JOUR AU - Borer, J. S. AU - Gordon, D. J. AU - Geller, N. L. PY - 2008 DA - 2008// TI - When should data and safety monitoring committees share interim results in cardiovascular trials? JO - JAMA VL - 299 UR - https://doi.org/10.1001/jama.299.14.1710 DO - 10.1001/jama.299.14.1710 ID - Borer2008 ER - TY - JOUR AU - Bloudoff-Indelicato, M. PY - 2015 DA - 2015// TI - Threat of interim data leaks prompts call for international rules JO - Nat Med VL - 21 UR - https://doi.org/10.1038/nm0315-200 DO - 10.1038/nm0315-200 ID - Bloudoff-Indelicato2015 ER - TY - STD TI - International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. http://www.ich.org/home.html. Accessed Dec 2015. UR - http://www.ich.org/home.html ID - ref8 ER - TY - STD TI - Who we are. 2017. http://www.who.int/about/who-we-are/en/. Accessed Dec 2015. UR - http://www.who.int/about/who-we-are/en/ ID - ref9 ER - TY - JOUR AU - Wong, G. AU - Greenhalgh, T. AU - Westhorp, G. AU - Buckingham, J. AU - Pawson, R. PY - 2013 DA - 2013// TI - RAMESES publication standards: meta-narrative reviews JO - BMC Med VL - 11 UR - https://doi.org/10.1186/1741-7015-11-20 DO - 10.1186/1741-7015-11-20 ID - Wong2013 ER - TY - JOUR AU - George, S. L. PY - 1993 DA - 1993// TI - A survey of monitoring practices in cancer clinical trials JO - Stat Med VL - 12 UR - https://doi.org/10.1002/sim.4780120507 DO - 10.1002/sim.4780120507 ID - George1993 ER - TY - JOUR AU - Geller, N. L. AU - Stylianou, M. PY - 1993 DA - 1993// TI - Practical issues in data monitoring of clinical trials: summary of responses to a questionnaire at NIH JO - Stat Med VL - 12 UR - https://doi.org/10.1002/sim.4780120520 DO - 10.1002/sim.4780120520 ID - Geller1993 ER - TY - JOUR AU - Tereskerz, P. M. AU - Guterbock, T. M. AU - Kermer, D. A. AU - Moreno, J. D. PY - 2011 DA - 2011// TI - An opinion and practice survey on the structure and management of data and safety monitoring boards JO - Account Res VL - 18 UR - https://doi.org/10.1080/08989621.2011.542680 DO - 10.1080/08989621.2011.542680 ID - Tereskerz2011 ER - TY - JOUR AU - Silverman, H. PY - 2007 DA - 2007// TI - Ethical issues during the conduct of clinical trials JO - Proc Am Thorac Soc VL - 4 UR - https://doi.org/10.1513/pats.200701-010GC DO - 10.1513/pats.200701-010GC ID - Silverman2007 ER - TY - JOUR AU - Slutsky, A. S. AU - Lavery, J. V. PY - 2004 DA - 2004// TI - Data safety and monitoring boards JO - N Engl J Med VL - 350 UR - https://doi.org/10.1056/NEJMsb033476 DO - 10.1056/NEJMsb033476 ID - Slutsky2004 ER - TY - JOUR AU - Fleming, T. R. AU - Sharples, K. AU - McCall, J. AU - Moore, A. AU - Rodgers, A. AU - Stewart, R. PY - 2008 DA - 2008// TI - Maintaining confidentiality of interim data to enhance trial integrity and credibility JO - Clin Trials VL - 5 UR - https://doi.org/10.1177/1740774508089459 DO - 10.1177/1740774508089459 ID - Fleming2008 ER - TY - JOUR AU - Rouse, D. J. PY - 2003 DA - 2003// TI - Data monitoring and safety committees and their operations JO - Obstet Gynecol Surv VL - 58 ID - Rouse2003 ER - TY - JOUR AU - Migrino, R. Q. AU - Topol, E. J. PY - 2003 DA - 2003// TI - A matter of life and death? The Heart Protection Study and protection of clinical trial participants JO - Control Clin Trials VL - 24 UR - https://doi.org/10.1016/S0197-2456(03)00091-6 DO - 10.1016/S0197-2456(03)00091-6 ID - Migrino2003 ER - TY - JOUR AU - Hemmings, R. AU - Day, S. PY - 2004 DA - 2004// TI - Regulatory perspectives on data safety monitoring boards: protecting the integrity of data JO - Drug Saf VL - 27 UR - https://doi.org/10.2165/00002018-200427010-00001 DO - 10.2165/00002018-200427010-00001 ID - Hemmings2004 ER - TY - BOOK PY - 2006 DA - 2006// TI - The establishment and operation of clinical trial data monitoring committees for clinical trial sponsors PB - US Food and Drug Administration CY - Rockville ID - ref20 ER - TY - JOUR AU - Eckstein, L. PY - 2015 DA - 2015// TI - Building a more connected DSMB: better integrating ethics review and safety monitoring JO - Account Res Policies Qual Assur VL - 22 ID - Eckstein2015 ER - TY - STD TI - International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). ICH Harmonised tripartite guideline; statistical principles for clinical trials E9. Geneva: ICH; 1998. p. 39. ID - ref22 ER - TY - JOUR AU - Chalmers, I. AU - Altman, D. G. AU - McHaffie, H. AU - Owens, N. AU - Cooke, R. W. PY - 2013 DA - 2013// TI - Data sharing among data monitoring committees and responsibilities to patients and science JO - Trials VL - 14 UR - https://doi.org/10.1186/1745-6215-14-102 DO - 10.1186/1745-6215-14-102 ID - Chalmers2013 ER - TY - JOUR AU - Shah, S. K. AU - Dawson, L. AU - Dixon, D. O. AU - Lie, R. K. PY - 2011 DA - 2011// TI - Should sponsors and DSMBs share interim results across trials? JO - J Acquir Immune Defic Syndr VL - 58 UR - https://doi.org/10.1097/QAI.0b013e318236eca3 DO - 10.1097/QAI.0b013e318236eca3 ID - Shah2011 ER - TY - BOOK PY - 2001 DA - 2001// TI - FDA guidance on clinical trial data monitoring committees (DMCs) PB - US Food and Drug Administration CY - Rockville ID - ref25 ER - TY - JOUR AU - Pocock, S. J. PY - 1993 DA - 1993// TI - Statistical and ethical issues in monitoring clinical trials JO - Stat Med VL - 12 UR - https://doi.org/10.1002/sim.4780121512 DO - 10.1002/sim.4780121512 ID - Pocock1993 ER - TY - JOUR AU - Chow, S. C. AU - Corey, R. AU - Lin, M. PY - 2012 DA - 2012// TI - On the independence of data monitoring committee in adaptive design clinical trials JO - J Biopharm Stat VL - 22 UR - https://doi.org/10.1080/10543406.2012.676536 DO - 10.1080/10543406.2012.676536 ID - Chow2012 ER - TY - JOUR AU - Fleming, T. R. AU - Hennekens, C. H. AU - Pfeffer, M. A. AU - DeMets, D. L. PY - 2014 DA - 2014// TI - Enhancing trial integrity by protecting the independence of data monitoring committees in clinical trials JO - J Biopharm Stat VL - 24 UR - https://doi.org/10.1080/10543406.2014.925719 DO - 10.1080/10543406.2014.925719 ID - Fleming2014 ER - TY - JOUR AU - D’Agostino, R. B. PY - 2004 DA - 2004// TI - The statistician and the data monitoring committee JO - Stat Med VL - 23 UR - https://doi.org/10.1002/sim.1873 DO - 10.1002/sim.1873 ID - D’Agostino2004 ER - TY - JOUR AU - Fleming, T. R. PY - 2006 DA - 2006// TI - Standard versus adaptive monitoring procedures: a commentary JO - Stat Med VL - 25 UR - https://doi.org/10.1002/sim.2641 DO - 10.1002/sim.2641 ID - Fleming2006 ER - TY - JOUR AU - Siegel, J. P. AU - O’Neill, R. T. AU - Temple, R. AU - Campbell, G. AU - Foulkes, M. A. PY - 2004 DA - 2004// TI - Independence of the statistician who analyses unblinded data JO - Stat Med VL - 23 UR - https://doi.org/10.1002/sim.1789 DO - 10.1002/sim.1789 ID - Siegel2004 ER - TY - STD TI - NHLBI policy for data and safety monitoring of extramural clinical studies. http://www.nhlbi.nih.gov/research/funding/human-subjects/data-safety-monitoring-policy. Accessed Dec 2015. UR - http://www.nhlbi.nih.gov/research/funding/human-subjects/data-safety-monitoring-policy ID - ref32 ER - TY - STD TI - Guidelines for NCCIH-appointed data and safety monitoring boards. https://nccih.nih.gov/research/policies/datasafety. Accessed Dec 2015. UR - https://nccih.nih.gov/research/policies/datasafety ID - ref33 ER - TY - JOUR AU - Sartor, O. AU - Halabi, S. PY - 2015 DA - 2015// TI - Independent data monitoring committees: an update and overview JO - Urol Oncol VL - 33 UR - https://doi.org/10.1016/j.urolonc.2014.12.013 DO - 10.1016/j.urolonc.2014.12.013 ID - Sartor2015 ER - TY - JOUR AU - Williams, G. W. AU - Davis, R. L. AU - Getson, A. J. AU - Gould, A. L. AU - Hwang, I. K. AU - Matthews, H. AU - Shih, W. C. J. AU - Snapinn, S. M. AU - Waltonbowen, K. L. PY - 1993 DA - 1993// TI - Monitoring of clinical trials and interim analyses from a drug sponsors point of view JO - Stat Med VL - 12 UR - https://doi.org/10.1002/sim.4780120513 DO - 10.1002/sim.4780120513 ID - Williams1993 ER - TY - JOUR AU - DeMets, D. AU - Califf, R. AU - Dixon, D. AU - Ellenberg, S. AU - Fleming, T. AU - Held, P. AU - Julian, D. AU - Kaplan, R. AU - Levine, R. AU - Neaton, J. PY - 2004 DA - 2004// TI - Issues in regulatory guidelines for data monitoring committees JO - Clin Trials VL - 1 UR - https://doi.org/10.1191/1740774504cn019xx DO - 10.1191/1740774504cn019xx ID - DeMets2004 ER - TY - JOUR AU - Delgado-Herrera, L. AU - Anbar, D. PY - 2003 DA - 2003// TI - A model for the interim analysis process: a case study JO - Control Clin Trials VL - 24 UR - https://doi.org/10.1016/S0197-2456(02)00275-1 DO - 10.1016/S0197-2456(02)00275-1 ID - Delgado-Herrera2003 ER - TY - JOUR AU - DeMets, D. L. AU - Fleming, T. R. PY - 2004 DA - 2004// TI - The independent statistician for data monitoring committees JO - Stat Med VL - 23 UR - https://doi.org/10.1002/sim.1786 DO - 10.1002/sim.1786 ID - DeMets2004 ER - TY - JOUR AU - Stephens, R. J. AU - Langley, R. E. AU - Mulvenna, P. AU - Nankivell, M. AU - Vail, A. AU - Parmar, M. K. PY - 2014 DA - 2014// TI - Interim results in clinical trials: do we need to keep all interim randomised clinical trial results confidential? JO - Lung Cancer VL - 85 UR - https://doi.org/10.1016/j.lungcan.2014.05.012 DO - 10.1016/j.lungcan.2014.05.012 ID - Stephens2014 ER - TY - JOUR AU - Green, S. AU - Crowley, J. PY - 1993 DA - 1993// TI - Data monitoring committees for Southwest Oncology Group clinical trials JO - Stat Med VL - 12 UR - https://doi.org/10.1002/sim.4780120508 DO - 10.1002/sim.4780120508 ID - Green1993 ER - TY - JOUR AU - Lilford, R. J. AU - Braunholtz, D. AU - Edwards, S. AU - Stevens, A. PY - 2001 DA - 2001// TI - Monitoring clinical trials - interim data should be publicly available JO - Br Med J VL - 323 UR - https://doi.org/10.1136/bmj.323.7310.441 DO - 10.1136/bmj.323.7310.441 ID - Lilford2001 ER - TY - JOUR AU - Miller, F. G. AU - Wendler, D. PY - 2008 DA - 2008// TI - Is it ethical to keep interim findings of randomised controlled trials confidential? JO - J Med Ethics VL - 34 UR - https://doi.org/10.1136/jme.2006.019109 DO - 10.1136/jme.2006.019109 ID - Miller2008 ER - TY - JOUR AU - Vail, A. AU - Hornbuckle, J. AU - Spiegelhalter, D. J. AU - Thornton, J. G. PY - 2001 DA - 2001// TI - Prospective application of Bayesian monitoring and analysis in an ‘open’ randomized clinical trial JO - Stat Med VL - 20 UR - https://doi.org/10.1002/sim.1171 DO - 10.1002/sim.1171 ID - Vail2001 ER - TY - JOUR AU - Fleming, T. R. AU - Ellenberg, S. AU - DeMets, D. L. PY - 2002 DA - 2002// TI - Monitoring clinical trials: issues and controversies regarding confidentiality JO - Stat Med VL - 21 UR - https://doi.org/10.1002/sim.1288 DO - 10.1002/sim.1288 ID - Fleming2002 ER - TY - JOUR AU - Glover, J. M. AU - Kay, R. PY - 2012 DA - 2012// TI - Who advises the Data Monitoring Committee (DMC)? A review of regulatory guidance for sponsors on DMCs after 5 years and advice for DMC members JO - Drug Inf J VL - 46 ID - Glover2012 ER - TY - JOUR AU - Califf, R. M. AU - Ellenberg, S. S. PY - 2001 DA - 2001// TI - Statistical approaches and policies for the operations of Data and Safety Monitoring Committees JO - Am Heart J VL - 141 UR - https://doi.org/10.1067/mhj.2001.113152 DO - 10.1067/mhj.2001.113152 ID - Califf2001 ER - TY - JOUR AU - Hicks, L. K. AU - Laupacis, A. AU - Slutsky, A. S. PY - 2007 DA - 2007// TI - A primer on data safety monitoring boards: mission, methods, and controversies JO - Intensive Care Med VL - 33 UR - https://doi.org/10.1007/s00134-007-0794-9 DO - 10.1007/s00134-007-0794-9 ID - Hicks2007 ER - TY - JOUR AU - DeMets, D. L. PY - 2000 DA - 2000// TI - Relationships between Data Monitoring Committees JO - Control Clin Trials VL - 21 UR - https://doi.org/10.1016/S0197-2456(99)00048-3 DO - 10.1016/S0197-2456(99)00048-3 ID - DeMets2000 ER - TY - JOUR AU - Dixon, D. O. AU - Lagakos, S. W. PY - 2000 DA - 2000// TI - Should data and safety monitoring boards share confidential interim data? JO - Control Clin Trials VL - 21 UR - https://doi.org/10.1016/S0197-2456(99)00042-2 DO - 10.1016/S0197-2456(99)00042-2 ID - Dixon2000 ER - TY - JOUR AU - Dixon, D. O. AU - Weiss, S. AU - Cahill, K. AU - Fox, L. AU - Love, J. AU - McNamara, J. AU - Soto-Torres, L. E. PY - 2011 DA - 2011// TI - Data and safety monitoring policy for National Institute of Allergy and Infectious Diseases clinical trials JO - Clin Trials VL - 8 UR - https://doi.org/10.1177/1740774511425181 DO - 10.1177/1740774511425181 ID - Dixon2011 ER - TY - JOUR AU - Yusuf AU - Whitley, R. AU - Assenzo, R. AU - Fleming, T. AU - Deykin AU - Hawkins, B. AU - Meier AU - Gent AU - Tognoni AU - Ellenberg, J. PY - 1993 DA - 1993// TI - The operation of data monitoring committees - discussion JO - Stat Med VL - 12 UR - https://doi.org/10.1002/sim.4780120519 DO - 10.1002/sim.4780120519 ID - Yusuf1993 ER - TY - JOUR AU - Ellenberg, S. S. PY - 2001 DA - 2001// TI - Independent data monitoring committees: rationale, operations and controversies JO - Stat Med VL - 20 UR - https://doi.org/10.1002/sim.730 DO - 10.1002/sim.730 ID - Ellenberg2001 ER - TY - JOUR AU - Wittes, J. AU - Barrett-Connor, E. AU - Braunwald, E. AU - Chesney, M. AU - Cohen, H. J. AU - Demets, D. AU - Dunn, L. AU - Dwyer, J. AU - Heaney, R. P. AU - Vogel, V. PY - 2007 DA - 2007// TI - Monitoring the randomized trials of the Women’s Health Initiative: the experience of the Data and Safety Monitoring Board JO - Clin Trials VL - 4 UR - https://doi.org/10.1177/1740774507079439 DO - 10.1177/1740774507079439 ID - Wittes2007 ER - TY - JOUR AU - Peppercorn, J. AU - Buss, W. G. AU - Fost, N. AU - Godley, P. A. PY - 2008 DA - 2008// TI - The dilemma of data-safety monitoring: provision of significant new data to research participants JO - Lancet VL - 371 UR - https://doi.org/10.1016/S0140-6736(08)60239-1 DO - 10.1016/S0140-6736(08)60239-1 ID - Peppercorn2008 ER - TY - JOUR AU - Fleming, T. R. PY - 2015 DA - 2015// TI - Protecting the confidentiality of interim data: addressing current challenges JO - Clin Trials VL - 12 UR - https://doi.org/10.1177/1740774514561243 DO - 10.1177/1740774514561243 ID - Fleming2015 ER - TY - JOUR AU - Nissen, S. E. PY - 2015 DA - 2015// TI - Commentary: confidentiality of interim trial data—the emerging crisis JO - Clin Trials VL - 12 UR - https://doi.org/10.1177/1740774514561661 DO - 10.1177/1740774514561661 ID - Nissen2015 ER - TY - BOOK AU - Parks, M. AU - Rosebraugh, C. AU - Jenkins, J. AU - Woodcock, J. PY - 2013 DA - 2013// TI - Memorandum; disclosure of interim cardiovascular risk study data NDA 22271 Nesina (alogliptin) tablets and its fixed dose combination product NDAs 22426 and 203414 PB - US Food and Drug Administration CY - Rockville ID - Parks2013 ER - TY - BOOK PY - 2014 DA - 2014// TI - Presentations for: Part 15 public hearing; confidentiality of interim results in cardiovascular (CV) outcomes safety trials PB - US Food and Drug Administration CY - Rockville ID - ref58 ER - TY - JOUR AU - London, A. J. PY - 2015 DA - 2015// TI - Commentary: data monitoring confidentiality and FDA transparency JO - Clin Trials VL - 12 UR - https://doi.org/10.1177/1740774514561047 DO - 10.1177/1740774514561047 ID - London2015 ER - TY - BOOK PY - 2014 DA - 2014// TI - Transcript for hearing: Part 15 public hearing; confidentiality of interim results in cardiovascular (CV) outcomes safety trials PB - US Food and Drug Administration CY - Rockville ID - ref60 ER - TY - STD TI - Confidentiality of Interim Results in Cardiovascular (CV) Outcomes Safety Trials; Part 15 - PUBLIC HEARING BEFORE THE COMMISSIONER; Request for Comments. http://www.fda.gov/Drugs/NewsEvents/ucm405023.htm. Accessed Dec 2015. UR - http://www.fda.gov/Drugs/NewsEvents/ucm405023.htm ID - ref61 ER - TY - JOUR AU - Gallo, P. PY - 2006 DA - 2006// TI - Operational challenges in adaptive design implementation JO - Pharm Stat VL - 5 UR - https://doi.org/10.1002/pst.221 DO - 10.1002/pst.221 ID - Gallo2006 ER - TY - JOUR AU - Gallo, P. AU - Chuang-Stein, C. AU - Dragalin, V. AU - Gaydos, B. AU - Krams, M. AU - Pinheiro, J. PY - 2006 DA - 2006// TI - Adaptive designs in clinical drug development—an Executive Summary of the PhRMA Working Group JO - J Biopharm Stat VL - 16 UR - https://doi.org/10.1080/10543400600614742 DO - 10.1080/10543400600614742 ID - Gallo2006 ER - TY - JOUR AU - Gallo, P. PY - 2006 DA - 2006// TI - Confidentiality and trial integrity issues for adaptive designs JO - Drug Inf J VL - 40 ID - Gallo2006 ER - TY - JOUR AU - Herson, J. PY - 2008 DA - 2008// TI - Coordinating data monitoring committees and adaptive clinical trial designs JO - Drug Inf J VL - 42 ID - Herson2008 ER - TY - JOUR AU - Antonijevic, Z. AU - Gallo, P. AU - Chuang-Stein, C. AU - Dragalin, V. AU - Loewy, J. AU - Menon, S. AU - Miller, E. R. AU - Morgan, C. C. AU - Sanchez, M. PY - 2013 DA - 2013// TI - Views on emerging issues pertaining to data monitoring committees for adaptive trials JO - Ther Innov Regul Sci VL - 47 UR - https://doi.org/10.1177/2168479013486996 DO - 10.1177/2168479013486996 ID - Antonijevic2013 ER - TY - JOUR AU - Day, S. PY - 2015 DA - 2015// TI - Data monitoring committees in clinical trials: best practice, complexities and considerations JO - Clin Invest VL - 5 UR - https://doi.org/10.4155/cli.15.31 DO - 10.4155/cli.15.31 ID - Day2015 ER - TY - JOUR AU - Gallo, P. AU - Fardipour, P. AU - Dragalin, V. AU - Krams, M. AU - Littman, G. S. AU - Bretz, F. PY - 2010 DA - 2010// TI - Data monitoring in adaptive dose-ranging trials JO - Stat Biopharm Res VL - 2 UR - https://doi.org/10.1198/sbr.2010.09043 DO - 10.1198/sbr.2010.09043 ID - Gallo2010 ER - TY - JOUR AU - Korn, E. L. AU - Hunsberger, S. AU - Freidlin, B. AU - Smith, M. A. AU - Abrams, J. S. PY - 2005 DA - 2005// TI - Preliminary data release for randomized clinical trials of noninferiority: a new proposal JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.02.105 DO - 10.1200/JCO.2005.02.105 ID - Korn2005 ER - TY - JOUR AU - Allardyce, R. A. AU - Bagshaw, P. F. AU - Frampton, C. M. AU - Frizelle, F. A. AU - Hewett, P. J. AU - Rieger, N. A. AU - Smith, J. S. AU - Solomon, M. J. AU - Stevenson, A. R. PY - 2011 DA - 2011// TI - Ethical issues with the disclosure of surgical trial short-term data JO - ANZ J Surg VL - 81 UR - https://doi.org/10.1111/j.1445-2197.2010.05433.x DO - 10.1111/j.1445-2197.2010.05433.x ID - Allardyce2011 ER - TY - JOUR AU - DeMets, D. L. PY - 2011 DA - 2011// TI - Commentary on Anand et al JO - Clin Trials VL - 8 UR - https://doi.org/10.1177/1740774511426581 DO - 10.1177/1740774511426581 ID - DeMets2011 ER - TY - JOUR AU - Rockhold, F. W. AU - Enas, G. G. PY - 1993 DA - 1993// TI - Data monitoring and interim analyses in the pharmaceutical industry: ethical and logistical considerations JO - Stat Med VL - 12 UR - https://doi.org/10.1002/sim.4780120512 DO - 10.1002/sim.4780120512 ID - Rockhold1993 ER - TY - JOUR AU - DeMets, D. L. AU - Fleming, T. R. AU - Whitley, R. J. AU - Childress, J. F. AU - Ellenberg, S. S. AU - Foulkes, M. AU - Mayer, K. H. AU - O’Fallon, J. AU - Pollard, R. B. AU - Rahal, J. J. PY - 1995 DA - 1995// TI - The data and safety monitoring board and acquired immune deficiency syndrome (AIDS) clinical trials JO - Control Clin Trials VL - 16 UR - https://doi.org/10.1016/S0197-2456(95)00073-9 DO - 10.1016/S0197-2456(95)00073-9 ID - DeMets1995 ER - TY - JOUR AU - Smith, M. A. AU - Ungerleider, R. S. AU - Korn, E. L. AU - Rubinstein, L. AU - Simon, R. PY - 1997 DA - 1997// TI - Role of independent data-monitoring committees in randomized clinical trials sponsored by the National Cancer Institute JO - J Clin Oncol VL - 15 UR - https://doi.org/10.1200/JCO.1997.15.7.2736 DO - 10.1200/JCO.1997.15.7.2736 ID - Smith1997 ER -